Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from AdAlta Ltd. ( (AU:1AD) ) is now available.
AdAlta Limited has issued 41,666,667 fully paid ordinary shares as part of its funding arrangements with NLSC, LLC, priced at $0.0018 per share. This move is part of the company’s strategy to manage its financial obligations and maintain compliance with the Corporations Act, potentially impacting its financial stability and investor relations.
More about AdAlta Ltd.
AdAlta Limited operates in the biotechnology industry, focusing on the development of innovative therapeutic products. The company’s primary offerings include novel biologic drugs aimed at addressing unmet medical needs, with a market focus on advancing healthcare solutions.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.68M
Learn more about 1AD stock on TipRanks’ Stock Analysis page.